Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 100 participants.
Also called NCT01878344
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT01878344
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Türkiye
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT01878344. Randomized; triple masking; primary purpose diagnostic. Start 2013-01 (actual); primary completion 2018-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention
- Acronym
- EASE-PRM-PCI
- Condition
- Acute ST Segment Elevation Myocardial Infarction
- Intervention (Drug)
- NAC
- Intervention (Drug)
- Saline
- Lead sponsor
- Suleyman Demirel University
Record details
- Record id
cardio:ct-nct01878344- Content hash
ed1e422adfbffbeaca2a0519b4b5f22849e4773824a49a3fca65b550e02f5454